Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C17H26N2O2.ClH |
| Molecular Weight | 326.861 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CNCCCC(C#N)(C(C)C)C1=CC(OC)=C(OC)C=C1
InChI
InChIKey=ARLOHZJIIHSRFE-UHFFFAOYSA-N
InChI=1S/C17H26N2O2.ClH/c1-13(2)17(12-18,9-6-10-19-3)14-7-8-15(20-4)16(11-14)21-5;/h7-8,11,13,19H,6,9-10H2,1-5H3;1H
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Verapamil: metabolism in cultures of primary human coronary arterial endothelial cells. | 2003 Jul |
|
| Aerobic biodegradability of the calcium channel antagonist verapamil and identification of a microbial dead-end transformation product studied by LC-MS/MS. | 2008 Jun |
|
| Synthesis and preclinical evaluation of [11C]D617, a metabolite of (R)-[11C]verapamil. | 2012 May |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
19382807
Created by
admin on Sat Dec 16 11:09:56 GMT 2023 , Edited by admin on Sat Dec 16 11:09:56 GMT 2023
|
PRIMARY | |||
|
67775-97-7
Created by
admin on Sat Dec 16 11:09:56 GMT 2023 , Edited by admin on Sat Dec 16 11:09:56 GMT 2023
|
PRIMARY | |||
|
J368YCA39W
Created by
admin on Sat Dec 16 11:09:56 GMT 2023 , Edited by admin on Sat Dec 16 11:09:56 GMT 2023
|
PRIMARY | |||
|
1711304
Created by
admin on Sat Dec 16 11:09:56 GMT 2023 , Edited by admin on Sat Dec 16 11:09:56 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD
